NCT03851081 Clinical Trials
Find a Pfizer study that’s right for you by searching for conditions, keywords or a National Clinical Trials (NCT) number. You can also see nearby clinical trials by entering your ZIP code or city.
1 - 1 of 1 Results
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blasts 5 Percent or More of Bone Marrow Nucleated Cells, Blasts 5 Percent or More of Peripheral Blood White Cells, CD22 Positive, Lymphoblasts 20 Percent or More of Bone Marrow
Inotuzumab Ozogamicin and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia
Buffalo, New York